Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Benitec Biopharma Inc (NASDAQ: BNTC) closed the day trading at $11.35 down -8.10% from the previous closing price of $12.35. In other words, the price has decreased by -$8.10 from its previous closing price. On the day, 1.94 million shares were traded. BNTC stock price reached its highest trading level at $12.6927 during the session, while it also had its lowest trading level at $10.94.
Ratios:
For a better understanding of BNTC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.80 and its Current Ratio is at 14.80. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 16, 2024, initiated with a Buy rating and assigned the stock a target price of $28.
On December 13, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $30.
On October 16, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $35.Oppenheimer initiated its Outperform rating on October 16, 2024, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 31 ’25 when SUVRETTA CAPITAL MANAGEMENT, L bought 16,497 shares for $12.83 per share. The transaction valued at 211,736 led to the insider holds 8,807,805 shares of the business.
SUVRETTA CAPITAL MANAGEMENT, L bought 900,000 shares of BNTC for $11,700,000 on Mar 26 ’25. The Director now owns 8,793,245 shares after completing the transaction at $13.00 per share. On Dec 23 ’24, another insider, SUVRETTA CAPITAL MANAGEMENT, L, who serves as the Director of the company, bought 27,502 shares for $10.98 each. As a result, the insider paid 301,972 and bolstered with 7,981,725 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BNTC now has a Market Capitalization of 297943200 and an Enterprise Value of 187938384.
Stock Price History:
The Beta on a monthly basis for BNTC is 0.40, which has changed by 0.5625 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, BNTC has reached a high of $17.15, while it has fallen to a 52-week low of $6.66. The 50-Day Moving Average of the stock is -21.05%, while the 200-Day Moving Average is calculated to be -5.54%.
Shares Statistics:
Over the past 3-months, BNTC traded about 64.75K shares per day on average, while over the past 10 days, BNTC traded about 354280 shares per day. A total of 25.55M shares are outstanding, with a floating share count of 24.55M. Insiders hold about 6.46% of the company’s shares, while institutions hold 87.70% stake in the company. Shares short for BNTC as of 1749772800 were 527600 with a Short Ratio of 8.15, compared to 1747267200 on 439202. Therefore, it implies a Short% of Shares Outstanding of 527600 and a Short% of Float of 3.6799999999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
